1. Home
  2. INTG vs CGTX Comparison

INTG vs CGTX Comparison

Compare INTG & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTG
  • CGTX
  • Stock Information
  • Founded
  • INTG 1965
  • CGTX 2007
  • Country
  • INTG United States
  • CGTX United States
  • Employees
  • INTG N/A
  • CGTX N/A
  • Industry
  • INTG Building operators
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTG Real Estate
  • CGTX Health Care
  • Exchange
  • INTG Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • INTG 28.9M
  • CGTX 23.1M
  • IPO Year
  • INTG N/A
  • CGTX 2021
  • Fundamental
  • Price
  • INTG $12.38
  • CGTX $0.33
  • Analyst Decision
  • INTG
  • CGTX Strong Buy
  • Analyst Count
  • INTG 0
  • CGTX 5
  • Target Price
  • INTG N/A
  • CGTX $6.13
  • AVG Volume (30 Days)
  • INTG 2.7K
  • CGTX 942.4K
  • Earning Date
  • INTG 05-23-2025
  • CGTX 05-07-2025
  • Dividend Yield
  • INTG N/A
  • CGTX N/A
  • EPS Growth
  • INTG N/A
  • CGTX N/A
  • EPS
  • INTG N/A
  • CGTX N/A
  • Revenue
  • INTG $59,656,000.00
  • CGTX N/A
  • Revenue This Year
  • INTG N/A
  • CGTX N/A
  • Revenue Next Year
  • INTG N/A
  • CGTX N/A
  • P/E Ratio
  • INTG N/A
  • CGTX N/A
  • Revenue Growth
  • INTG 4.33
  • CGTX N/A
  • 52 Week Low
  • INTG $10.70
  • CGTX $0.31
  • 52 Week High
  • INTG $24.67
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • INTG 44.94
  • CGTX 39.84
  • Support Level
  • INTG $11.47
  • CGTX $0.30
  • Resistance Level
  • INTG $12.68
  • CGTX $0.34
  • Average True Range (ATR)
  • INTG 0.59
  • CGTX 0.03
  • MACD
  • INTG -0.08
  • CGTX -0.01
  • Stochastic Oscillator
  • INTG 42.96
  • CGTX 28.31

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: